$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long does it take for Apelvis to take effect? What are the factors that affect the efficacy of
2026-02-01 22:25:32
Check Details
How effective is selumetinib in treating neurofibromatosis? Can it alleviate the condition in the long term?
2026-02-01 22:25:32
Check Details
How effective is cabozantinib in the treatment of brain metastases? Whether the disease can be effectively controlled
2026-02-01 22:25:32
Check Details
How long should I take bedaquiline? What medication schedule needs to be followed during treatment?
2026-02-01 22:25:32
Check Details
What is the dosage of dasatinib? How to adjust the dose according to the patient's condition?
2026-02-01 22:25:32
Check Details
Can Anamorelin be used long term? Safety and potential risks of long-term use
2026-02-01 22:25:32
Check Details
Can't I stop taking baricitinib once I start taking it? Long-term use requirements and discontinuation precautions
2026-02-01 22:25:32
Check Details
Is ruxolitinib cream effective in treating eczema? How it compares to other eczema treatments
2026-02-01 22:25:32
Check Details
Will upadatinib develop wildly after discontinuation? Is there a risk of recurrence or worsening of symptoms after discontinuing medication?
2026-02-01 22:25:32
Check Details
Pitobrutinib/pitobrutinib receives positive CHMP review for R/R CLL following use of covalent BTK inhibitor
2026-02-01 22:25:32
Check Details
Talazoparib/talazopanib combined with enzalutamide as first-line treatment for mCRPC improves OS
2026-02-01 22:25:32
Check Details
What are the side effects of Crizotinib/Xalkori? How to respond scientifically
2026-02-01 22:25:32
Check Details
1
2
...
1455
1456
1457
1458
1459
1460
1461
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
2
Cemiplimab Storage and Handling Guide
3
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
6
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
7
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
8
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
9
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
10
Tazemetostat: Mechanism, Standard Dosing, and the 2026 Global Withdrawal of the First-in-Class EZH2 Inhibitor
11
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
12
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer